Emerging Pathogen Threats Michael Olesen

Similar documents
Drug resistance TB in People Living with HIV: research questions and priorities.

XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps

XDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine

What can be done against XDR-TB?

The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Main developments in past 24 hours

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

THE CARE WE PROMISE FACTS AND FIGURES 2017

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

Global Measles and Rubella Update November 2018

3.1 PHASE 2 OF THE GLOBAL PROJECT

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB

Pandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

Global Measles and Rubella Update. April 2018

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

The epidemiology of tuberculosis

Acknowledgements. Wild birds and the risk of a pandemic. Overview of the presentation

Global EHS Resource Center

Global Measles and Rubella Update October 2018

Recommended composition of influenza virus vaccines for use in the 2007 influenza season

How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008

Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank

Eligibility List 2018

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers NZ & Australia

FAOAIDEnews Animal Influenza Disease Emergency

Appendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479

STAT/SOC/CSSS 221 Statistical Concepts and Methods for the Social Sciences. Introduction to Mulitple Regression

HIV and Harm Reduction in Prisons

#4 (Tuberculosis OR TB OR Pulmonary Tuberculosis OR Multi-Drug Resistant Tuberculosis OR MDR OR Extremely-Drug Resistant Tuberculosis or XDR)

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS

2. Treatment coverage: 3. Quality of care: 1. Access to diagnostic services:

O c t o b e r 1 0,

ICM: Trade-offs in the fight against HIV/AIDS

Terms and Conditions. VISA Global Customer Assistance Services

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE)

Current Situation on Avian Influenza and the pandemic threat

ADMINISTRATIVE AND FINANCIAL MATTERS. Note by the Executive Secretary * CONTENTS. Explanatory notes Tables. 1. Core budget

מדינת ישראל. Tourist Visa Table

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts

Summary. Primary care data. Week 49/2014. Season

CND UNGASS FOLLOW UP

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Seizures of ATS (excluding ecstasy ), 2010

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Alcohol-related harm in Europe and the WHO policy response

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

Name of the presenter

The State of Measles and Rubella in the WHO European Region

ESPEN Congress Geneva 2014 FOOD: THE FACTOR RESHAPING THE SIZE OF THE PLANET

JOINT TB AND HIV PROGRAMMING

The cancer burden in the European Union and the European Region: the current situation and a way forward

World Connections Committee (WCC) Report

Annual prevalence estimates of cannabis use in the late 1990s

3.5 Consumption Annual Prevalence Opiates

FRAMEWORK CONVENTION ALLIANCE BUILDING SUPPORT FOR TOBACCO CONTROL. Smoke-free. International Status Report

Appendix F: Test-Curriculum Matching Analysis

Influenza Severity Assessment PISA project

European status report on alcohol and health Leadership, awareness and commitment

Highlighting in the WHO European Region:

WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Guidance for Travelers on Temporary Work Assignment Abroad

WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

Differences make a Difference

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

#1 #2 OR Immunity verified by immune titer (please attach report) * No titer needed if proof of two doses of Varicella provided

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Recommended composition of influenza virus vaccines for use in the 2009 southern hemisphere influenza season

Epidemiology of Legionnaires Disease in Europe Birgitta de Jong on behalf of ELDSNet ESGLI conference 22 September 2016

Annex 2 A. Regional profile: West Africa

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

1. Consent for Treatment This form must be completed in order to receive healthcare services in the campus clinic.

Access to treatment and disease burden

ANNEX 3: Country progress indicators

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Polio Eradication and Surveillance. December

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

The Test-Curriculum Matching Analysis: Science

WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT

WHO Global Status Report on Alcohol 2004

Key issues for HIV testing and

Updates on the global TB Global TB burden Policy response Treatment approaches

Drug-resistant Tuberculosis

THE GLOBAL HEALTH SECURITY AGENDA. We have to change our mindsets and start thinking about biological threats as the security threats that they are.

Maternal Deaths Disproportionately High in Developing Countries

Challenges and Opportunities to Optimizing the HIV Care Continuum Can We Test and Treat Enough People to Make a Seismic Difference by 2030?

511,000 (57% new cases) ~50,000 ~30,000

Global Fund Mid-2013 Results

GLOBAL FMD SITUATION DURING 2001/2002

BCG. and your baby. Immunisation. Protecting babies against TB. the safest way to protect your child

Transcription:

Emerging Pathogen Threats Michael Olesen

Clinical Considerations - Evaluation MRSA belongs in the differential diagnosis of skin and soft tissue infections (SSTI s) compatible with S. aureus infection:

MRSA Surveillance Areas

Prevalence (%) S. aureus Nasal Colonization National Health and Nutrition Examination Survey 2001-02 50 45 40 S. aureus: 32.4% = 89.4 M people 35 30 25 20 15 10 5 0 1--5 6--11 12--19 20--29 30--39 40--49 50--59 60--69 70+ Age (years) Male Female MRSA: 0.8% = 2.3 M people MRSA colonization associated with age >= 60 years & being female

Percent Resistance Methicillin-Resistant Staphylococcus aureus (MRSA) Among Intensive Care Unit Patients, 1995-2004 70 60 50 40 30 20 10 0 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 Year Source: National Nosocomial Infections Surveillance (NNIS) System

Percent Resistance Vancomycin-Resistant Enterococci (VRE) Among Intensive Care Unit Patients,1995-2004 35 30 25 20 15 10 5 0 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 Year Source: National Nosocomial Infections Surveillance (NNIS) System

Percent Resistance Fluoroquinolone-Resistant Pseudomonas aeruginosa Among Intensive Care Unit Patients, 1995-2004 40 35 30 25 20 15 10 5 0 1995 1996 1997 1998 1999 2000 Year 2001 2002 2003 Source: National Nosocomial Infections Surveillance (NNIS) System 2004

Tuberculosis

No. of Cases 30,000 Reported TB Cases United States, 1982 2010* 25,000 20,000 15,000 10,000 5,000 0 *Updated as of July 21, 2011 Year

TB Case Rates,* United States, 2010 D.C. *Cases per 100,000. < 3.6 (2010 national average) >3.6

Percentage of TB Cases Among Foreign-born Persons, United States* 2000 2010 DC DC *Updated as of July 21, 2011 >50% 25% 49% <25%

Available data on anti-tb drug resistance, 2010 Nationwide surveillance data Subnational surveillance data Nationwide recent survey data (since 2000) Subnational and/or old survey data (before 2000) No data available The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO 2011. All rights reserved

Proportions of MDR among previously treated TB cases, 1994-2010 0-<6 6-<12 12-<30 30-<50 >50 No data available Subnational data only The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO 2011. All rights reserved

Proportions of MDR among new TB cases, 1994-2010 0-<3 3-<6 6-<12 12-<18 >18 No data available Subnational data only The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO 2011. All rights reserved

Estimated absolute number of MDR-TB cases, 2009 0-<4,000 4,000-<10,000 10,000-<40,000 approximately 100,000 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO 2011. All rights reserved

Countries that had reported at least one XDR-TB case by end 2010 Argentina Bhutan France Kazakhstan Nepal Republic of Moldova Togo Armenia Cambodia Georgia Kenya Netherlands Romania Tunisia Australia Canada Germany Kyrgyzstan Norway Russian Federation Ukraine Austria Chile Greece Latvia Pakistan Slovenia United Arab Emirates Azerbaijan China India Lesotho Peru South Africa United Kingdom Bangladesh Colombia Iran (Islamic Rep. of) Lithuania Philippines Spain United States of America Belgium Czech Republic Ireland Mexico Poland Swaziland Uzbekistan Botswana Ecuador Israel Mozambique Portugal Sweden Viet Nam Brazil Egypt Italy Myanmar Qatar Tajikistan Burkina Faso Estonia Japan Namibia Republic of Korea Thailand The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO 2011. All rights reserved

Emerging Diseases XDRTB

XDR TB Andrew Speaker

TDR TB

Consumer product antibacterials

Animal Husbandry Institute of Medicine. 1990. Human health risks with the subtherapeutic use of penicillin or tetracyclines in animal feeds. National Academy Press, Washington, D.C.

Animal Husbandry 80% of abx used in animals are to promote growth (15-17 million lbs. annually in US) 30x more animals receive abx than humans Animals produce 5-400x more feces Vector transmission Fertilizer Tetracycline dosage change over time 1950s: 5-10 ppm Today: 50-200 ppm (10-20x increase)

Recommended Reading

The Cost of HAI 5.4 excess days of hospitalization per infection Am J Med Qual. 2009 Jan-Feb;24(1):71-3.

Infection Prevention and Health Care Finance Effect on the Bottom Line Profit Reimbursement $0 Time (LOS) Loss

Infection Prevention and Health Care Finance Effect on the Bottom Line Profit Reimbursement $0 Time (LOS) Loss HAI

The Cost of HAI 5.4 excess days of hospitalization per infection $12,197-15,275 per infection Am J Med Qual. 2009 Jan-Feb;24(1):71-3.

Calculation of estimates of healthcare-associated infections in U.S. hospitals among adults and children outside of intensive care units, 2002 263,810 274,098-967 -21-28,725 244,385 TOTAL HRN WBN Non-newborn ICU = SSI SSI 20% Other 22% BSI 11% 133,368 129,519 PNEU 11% UTI 36% 424,060 HRN = high risk newborns WBN -= well-baby nurseries ICU = intensive care unit SSI = surgical site infections BSI bloodstream infections UTI = urinary infections PNEU = pneumonia Klevens, Edwards, Richards, et al. Pub Health Rep 2007;122:160-6

Costs by Type of Infection VAP: $25,072 BSI: $23,242 SSI: $10,478 MRSA: $5,980 MRSA SSI: $61,681 Anderson, DJ, Kirkland, KB, Kanafani, ZA, Engemann, JJ, Thacker P, Kaye, KS, Sexton, DJ. Cost of Healthcare-Associated Infections (HAI) and Hospital Budgets for Infection Control and Prevention (IC): Just a Drop in the Ocean? 17th Annual Society for Healthcare Epidemiology in America meeting, Baltimore, MD, April, 2007 Anderson DJ, Kaye KS, Chen LF, et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS ONE. 2009;4(12):e8305.

The Cost of HAI 5.4 excess days of hospitalization per infection $12,197-15,275 per infection 98,987 deaths Am J Med Qual. 2009 Jan-Feb;24(1):71-3.

Outbreaks of MRSA in the Community Often first detected as clusters of abscesses or spider bites Various settings Sports participants Inmates in correctional facilities Military recruits Daycare attendees Native Americans / Alaskan Natives Men who have sex with men Tattoo recipients Hurricane evacuees in shelters

US Yellow Fever Outbreaks, c. 1800-1900 Philadelphia; August-November 1793; approximately 5,000 dead New York City; July-October 1795; 730 dead Boston, New York City and Philadelphia; Summer 1798; more than 5,000 dead Baltimore; Summer 1800; 1,200 dead New Orleans; Summer 1853; 8000 or more dead Norfolk; June-Oct 1855; 2,000 dead Mississippi Valley; May-Oct 1878; 20,000 dead Cuba; Summer 1898; hundreds dead. New Orleans; May-October 1905; more than 900 dead

Walter Reed (1851-1902) Spread through mosquito vector instead of contact transmission Led to the ability to complete the Panama Canal

1870

MMWR 58(SS02);1-16

Emerging Diseases Pandemic Influenza

J Infect Dis. 2012 Feb 7 Influenza and COD

Recent Research Controversy 62

Camp Devens, Mass., Surgical Ward No 16 (Base Hospital) 9/29/1918 These men start with what appears to be an ordinary attack of LaGrippe or Influenza, and when brought to the hospital they very rapidly develop the most viscous type of Pneumonia that has ever been seen. Two hours after admission they have the Mahogany spots over the cheek bones, and a few hours later you can begin to see the cyanosis extending from their ears and spreading all over the face, until it is hard to distinguish the coloured men from the white. It is only a matter of a few hours then until death comes, and it is simply a struggle for air until they suffocate. It is horrible. One can stand it to see one, two or twenty men die, but to see these poor devils dropping like flies sort of gets on your nerves. We have been averaging about 100 deaths per day, and still keeping it up. There is no doubt in my mind that there is a new mixed infection here... they all mean but one thing here pneumonia and that means in about all cases death.

Presentation in chickens

What does 300M deaths mean? 250,000 deaths from the December 26, 2004 tsunami Imagine a tsunami of that scale EVERY HOUR for a six week period

Role of Antibiotic Resistance 1918-1919, 50% deaths due to 2 PN 1968-1969 33% mortality rate from 2 PN Will MRSA pneumonia, play a role in the next pandemic? MRSA attaches easier to cells infected with influenza Agwu, A., K. M. Brady, et al. (2007). "Cholera-like diarrhea and shock associated with community-acquired methicillin-resistant Staphylococcus aureus (USA400 clone) pneumonia." Pediatr Infect Dis J 26(3): 271-3. (2007). "Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--louisiana and Georgia, December 2006-January 2007." MMWR Morb Mortal Wkly Rep 56(14): 325-9.

Immune Systems - 1918 versus today Antibiotic Resistance Immunosuppression HIV/AIDS Chemotherapy Organ transplant 25% of military/police forces in Africa are HIV+

From barbarism to civilization requires a century, from civilization to barbarism needs but a day. - Will Durant (1885-1981) Durant W. The Reformation. Simon & Schuster; 1980.

Male Female 2005 85 80 75 70 65 60 55 50 45 40 35 30 25 20 15 10 5 Population (millions) 14 12 10 8 6 4 2 0 0 2 4 6 8 10 12 14 0

Male Female 2005 85 80 75 70 65 60 55 50 45 40 35 30 25 20 15 10 5 Population (millions) 14 12 10 8 6 4 2 0 0 2 4 6 8 10 12 14 0

Surge Capability and Surge Capacity Surge Capability the ability to manage patients requiring unusual or very specialized medical evaluation and intervention, often for uncommon medical conditions i.e., mix Surge Capacity the ability to manage increased patient care volume that otherwise would severely challenge or exceed the existing medical infrastructure i.e., numbers Barbera J, Macintyre A. Medical Surge Capacity and Capability: A System Template for Managing Medical and Health Resources during Large-Scale Emergencies. U.S. Department of Health and Human Services. Washington, D.C. August, 2004.

Surge Capability

What is surge capacity?

Military Hospital Surge Capacity Camp Devens (above near Boston) Built for 1200 Surge capacity: 2500 Census: 6000 Camp Grant (Rockford, IL) Went from census of 610 to 4102 in 6 days The base commander committed suicide

US Hospital Surge Capacity 955,768 licensed beds 707,268 staffed beds 96% of hospital beds occupied during seasonal flu During pandemic mirroring 1918 100,000,000 Americans sick 50,000,000 require care 25,000,000 s/s ARDS 12,500,000 require intubation 6,250,000 will die

National Ventilator Surge Capacity and Ethics ~105,000 in US 75,000 80,000 in use at any given time 100,000+ in use during normal flu season <6 per hospital in survey Who should get a ventilator? Osterholm, M. (2005). NEJM 352(18): 1839 Kaji, A. H. (2006). Acad Emerg Med 13(11): 1198

Can shortages happen today? Gasoline After onset of military action After Hurricane Katrina Food Will a pandemic trigger a rush to grocers in a similar manner? OTC pharmaceuticals Shelves were emptied in 1918 Clin Infect Dis 31(6): 1409-13. 80% of pharmaceuticals are produced overseas

Isolation

Extreme times call for extreme measures

Disease/Climate Interaction

olesen.michael@gmail.com